Met Life Investment Management, LLC Hille Vax, Inc. Transaction History
Met Life Investment Management, LLC
- $16.6 Billion
- Q2 2024
A detailed history of Met Life Investment Management, LLC transactions in Hille Vax, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 17,118 shares of HLVX stock, worth $30,127. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,118
Previous 14,395
18.92%
Holding current value
$30,127
Previous $239,000
3.35%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding HLVX
# of Institutions
93Shares Held
40.5MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.6MShares$18.7 Million9.05% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY4MShares$7.05 Million1.22% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.48MShares$6.13 Million0.03% of portfolio
-
Black Rock Inc. New York, NY2.09MShares$3.68 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.99MShares$3.5 Million0.01% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $58.8M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.